|
Video: What is a Stock Split?
|
|
Echo Therapeutics is a medical device company. Co. is developing its non-invasive, wireless continuous glucose monitoring (CGM) system for the wearable-health consumer market and diabetes outpatient market. Co.'s key product is a non-invasive (needle-free), wireless, continuous glucose monitoring system designed to provide glucose data. The CGM System includes a skin preparation device, transdermal glucose sensor, and wireless transmitter. The skin preparation device incorporates its patented micro-abrasion technology into a hand-held device used to prepare a small area of the skin. The non-invasive sensor is applied to this prepared area in order to measure the interstitial glucose levels. According to our ECTE split history records, ECTE has had 1 split. | |
|
ECTE (ECTE) has 1 split in our ECTE split history database. The split for ECTE took place on June 07, 2013. This was a 1 for 10 reverse split, meaning for each 10 shares of ECTE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as ECTE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ECTE split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ECTE shares, starting with a $10,000 purchase of ECTE, presented on a split-history-adjusted basis factoring in the complete ECTE split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/09/2014 |
|
End date: |
11/02/2018 |
|
Start price/share: |
$1.40 |
|
End price/share: |
$0.01 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.29% |
|
Average Annual Total Return: |
-71.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$71.40 |
|
Years: |
3.90 |
|
|
|
Date |
Ratio |
06/07/2013 | 1 for 10 |
|
|